Programme DES Nations Unies Pharmaceutical Import Profile — Tanzania (DGFT 2022–2026)

Name: Programme DES Nations Unies Pharmaceutical Import Records from India — 2 Products, $1.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Programme DES Nations Unies — Pharmaceutical Importer Profile (2026) | 2 Products, $1.6M Trade | TransData Nexus

Programme DES Nations Unies

Pharmaceutical Importer · Tanzania · Advanced Antibiotics Focus · $1.6M Total Trade · DGFT Verified

Programme DES Nations Unies is a pharmaceutical importer based in Tanzania with a total trade value of $1.6M across 2 products in 1 therapeutic categories. Based on 33 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Programme DES Nations Unies sources from 9 verified Indian suppliers, with Ipca Laboratories Limited accounting for 24.4% of imports.

Programme DES Nations Unies — Import Portfolio & Supplier Network

Programme DES Nations Unies import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Programme DES Nations Unies?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Ipca Laboratories Limited	$1.2M	38	24.4%
Cipla Limited	$1.1M	50	22.8%
Micro Labs Limited	$1.0M

What Formulations Does Programme DES Nations Unies Import?

Formulation	Value	Ships
Trimethoprim and sulfamethoxazole	$619.7K	14
Dolutegravir as sodium + lamivudine + tenofovir disoproxil fumarate tablets 50 / 300 / 300 MG	$200.0K	4
Harmless medicines: artemeter 20MG and	$182.5K	4
Dolutegravir as sodium lamivudine tenofovir disoproxil fumarate tablets 50 300 300 MG 12960 packs x1x90s	$150.0K	3
Harmless medicines:artesunate(+sodium bicarbonate 5% ampoule+sodium chloride 0.9% ampoule)60MG powder in	$150.0K	3
Trimethoprim and sulfamethoxazole tablets BP 160 MG/800 MG (10x10') (qty 45632	$124.1K	3
Dolutegravir as sodium lamivudine tenofovir disoproxil fumarate tablets 50 300 300 MG qty 12 960 Pack Pack size	$100.0K	2
Atazor r 300 100MG tablets atazanavir 300MG ritonavir USP 100MG 1x30tabs inv no 2302100441 dt 22 02 2023 1pac	$100.0K	2
Dolutegravir as sodium + lamivudine + tenofovir disoproxil fumarate tablets 50 / 300 / 300 MG	$100.0K	2
Dolutegravir as sodium + lamivudine + tenofovir disoproxil fumarate tablets 50 / 300 / 300 MG	$100.0K	2
Rifampicin 150MG / isoniazid 75MG tabs b.no.sl1017 sl1018 manufacturing .dt 08-2023 exp	$100.0K	2
Rifampicin 150MG/isoniazid 75MG/pyrazinamide 400MG /ethambutol 275MG tabs b.nosl3545sl3546sl3547 manufacturing	$100.0K	2
Trimethoprime and supfamethoxazole	$89.7K	3
Pharmaceutical products (finished	$87.5K	2
Pharma : 2 fdc (150/75) tablets paho (eng/sp/por/fr) (rifampin 150MG + isoniazid75mg) - 1boxx24x28	$67.7K	2

Programme DES Nations Unies imports 115 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Trimethoprim	Advanced Antibiotics	$900.0K	18	3.4%	2
2	Sulfamethoxazole	Advanced Antibiotics	$750.0K	15	3.8%	2

Programme DES Nations Unies imports 2 pharmaceutical products across 1 categories into Tanzania totaling $1.6M.

Programme DES Nations Unies — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Programme DES Nations Unies is a pharmaceutical importer based in Tanzania, specializing in the procurement of finished pharmaceutical formulations. Operating as a key player in the Tanzanian healthcare sector, the company sources a diverse range of medications to meet the country's medical needs. While specific details about its parent company and exact headquarters location are not publicly disclosed, Programme DES Nations Unies plays a pivotal role in ensuring the availability of essential medicines across Tanzania.

2Distribution Network

The company maintains a robust distribution network within Tanzania, ensuring efficient delivery of pharmaceutical products to various healthcare facilities, including hospitals, clinics, and pharmacies. While specific warehouse locations and logistics capabilities are not publicly detailed, Programme DES Nations Unies's extensive import activities suggest a well-established infrastructure capable of handling significant volumes of pharmaceutical goods.

3Industry Role

Programme DES Nations Unies functions primarily as a pharmaceutical importer, sourcing finished pharmaceutical formulations from international suppliers to meet the domestic demand in Tanzania. Its role is crucial in bridging the gap between global pharmaceutical manufacturers and the Tanzanian market, ensuring the availability of a wide range of medications necessary for public health.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Programme DES Nations Unies

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

The company's sourcing strategy exhibits a high degree of concentration, with a significant portion of its imports originating from a select group of Indian pharmaceutical manufacturers. This concentrated sourcing approach may present risks related to supply chain disruptions, such as geopolitical tensions or regulatory changes in the supplier's country. However, the consistent volume of shipments from these suppliers indicates a stable and well-established relationship, suggesting that Programme DES Nations Unies has effectively managed these potential risks through strategic partnerships and robust supply chain management practices.

2Supply Chain Resilience

Programme DES Nations Unies's supply chain resilience is closely tied to the stability and reliability of its Indian suppliers. The company's diverse portfolio of 115 unique formulations indicates a strategic approach to sourcing, potentially mitigating risks associated with over-reliance on a single product or supplier. While specific details about backup suppliers and shipping routes are not publicly available, the company's consistent import activities suggest a well-structured supply chain capable of adapting to potential disruptions.

3Strategic Implications

Importing Pharmaceuticals into Tanzania — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Tanzania

1Regulatory Authority & Framework

The Tanzania Medicines and Medical Devices Authority (TMDA) is the primary regulatory body overseeing the importation and exportation of pharmaceutical products in Tanzania. Established under the Tanzania Medicines and Medical Devices Act, Cap. 219, TMDA is responsible for ensuring the quality, safety, and efficacy of medicines and medical devices within the country. Key legislation governing pharmaceutical imports includes the Tanzania Food, Drugs, and Cosmetics Act, 2003, which outlines the regulatory framework for drug registration, importation, and distribution. The marketing authorization pathway for Indian generics involves obtaining registration from TMDA, which requires compliance with specific guidelines and submission of necessary documentation.

2Import Licensing & GMP

Importers of pharmaceutical products in Tanzania must obtain a valid import permit from TMDA, which involves registering their premises with the authority. The premises must be supervised by a registered pharmacist and comply with Good Manufacturing Practice (GMP) standards. TMDA recognizes GMP certificates from reputable authorities, including the European Union (EU), World Health Organization (WHO), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Additionally, importers must hold a valid business permit and adhere to all regulatory requirements set forth by TMDA.

Programme DES Nations Unies — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Programme DES Nations Unies's focus on advanced antibiotics, particularly trimethoprim and sulfamethoxazole, aligns with the prevalent need for effective antimicrobial treatments in Tanzania. The high import values and significant market share of these products indicate a strategic emphasis on addressing infectious diseases, which remain a major public health concern in the country. The consistent demand for these antibiotics suggests a stable market for such therapeutic areas, driven by both public health needs and the prevalence of bacterial infections.

2Sourcing Profile

The company's sourcing strategy is centered on generic drug formulations, primarily sourced from India, which is known for its robust pharmaceutical manufacturing sector. This approach allows Programme DES Nations Unies to offer cost-effective medications without compromising on quality. The diverse range of 115 unique formulations indicates a comprehensive procurement strategy aimed at meeting the varied therapeutic needs of the Tanzanian population.

3Market Positioning

Based on its product mix, Programme DES Nations Unies serves a broad segment of the Tanzanian pharmaceutical market, including retail pharmacies, hospitals, and government tenders. The company's extensive import activities and focus on essential medications position it as a key supplier in the country's healthcare system, contributing significantly to the availability of necessary treatments across various healthcare settings.

Seller's Guide — How to Become a Supplier to Programme DES Nations Unies

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Tanzanian market by partnering with Programme DES Nations Unies. The company's established distribution network and focus on essential medications provide a platform for introducing additional products that meet the regulatory standards set by TMDA. Potential gaps in the current sourcing strategy, such as the need for alternative suppliers or additional product formulations, present avenues for collaboration and market expansion.

2Requirements & Qualifications

Indian exporters seeking to supply Programme DES Nations Unies and the Tanzanian market must ensure that their products are registered with TMDA and comply with the authority's guidelines for importation. This includes obtaining GMP certification from recognized bodies, ensuring that products meet the required quality and labeling standards, and adhering to all regulatory requirements set forth by TMDA. Additionally, exporters must be prepared to navigate the import permit process, which involves submitting applications at least six weeks prior to the arrival of the consignment.

3How to Approach

Frequently Asked Questions — Programme DES Nations Unies

What products does Programme DES Nations Unies import from India?

Programme DES Nations Unies imports 2 pharmaceutical products across 1 categories. Top imports: Trimethoprim ($900.0K), Sulfamethoxazole ($750.0K).

Who supplies pharmaceuticals to Programme DES Nations Unies from India?

Programme DES Nations Unies sources from 9 verified Indian suppliers. The primary supplier is Ipca Laboratories Limited (24.4% of imports, $1.2M).

What is Programme DES Nations Unies's total pharmaceutical import value?

Programme DES Nations Unies's total pharmaceutical import value from India is $1.6M, based on 33 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Programme DES Nations Unies focus on?

Programme DES Nations Unies imports across 1 categories. The largest: Advanced Antibiotics (100.0%).

Get Full Programme DES Nations Unies Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.